Jun Kang

694 total citations
26 papers, 494 citations indexed

About

Jun Kang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jun Kang has authored 26 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 8 papers in Oncology. Recurrent topics in Jun Kang's work include Nutrition and Health in Aging (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Jun Kang is often cited by papers focused on Nutrition and Health in Aging (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Vascular Tumors and Angiosarcomas (3 papers). Jun Kang collaborates with scholars based in China, South Korea and United Kingdom. Jun Kang's co-authors include Seong Ho Park, Hucheng Wang, Yong He, Jae Ho Byun, Li Li, Heon‐Ju Kwon, Ah Young Kim, Seung Soo Lee, Sung Won Park and Kyung Won Kim and has published in prestigious journals such as Cancer Letters, American Journal of Roentgenology and The Annals of Thoracic Surgery.

In The Last Decade

Jun Kang

25 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Kang China 12 185 184 137 98 73 26 494
Ayako Nakanome Japan 13 95 0.5× 111 0.6× 224 1.6× 67 0.7× 29 0.4× 44 516
Takao Takahashi Japan 12 89 0.5× 126 0.7× 286 2.1× 32 0.3× 31 0.4× 61 514
Dong Hae Chung South Korea 13 74 0.4× 116 0.6× 203 1.5× 23 0.2× 126 1.7× 64 474
Junya Oguma Japan 14 114 0.6× 319 1.7× 477 3.5× 67 0.7× 43 0.6× 94 653
Faik Sarıalioğlu Türkiye 12 101 0.5× 71 0.4× 144 1.1× 29 0.3× 74 1.0× 54 481
Jaeim Lee South Korea 12 110 0.6× 89 0.5× 215 1.6× 61 0.6× 37 0.5× 62 463
Khoon Leong Chuah Singapore 12 131 0.7× 172 0.9× 84 0.6× 117 1.2× 41 0.6× 36 544
William J. Grist United States 12 68 0.4× 189 1.0× 220 1.6× 50 0.5× 55 0.8× 15 487
Omar Racchi Italy 11 105 0.6× 48 0.3× 57 0.4× 87 0.9× 84 1.2× 19 463
Arzu Okur Türkiye 12 66 0.4× 54 0.3× 36 0.3× 26 0.3× 27 0.4× 38 286

Countries citing papers authored by Jun Kang

Since Specialization
Citations

This map shows the geographic impact of Jun Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Kang more than expected).

Fields of papers citing papers by Jun Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Kang. The network helps show where Jun Kang may publish in the future.

Co-authorship network of co-authors of Jun Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Kang. A scholar is included among the top collaborators of Jun Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Kang. Jun Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Rui, Caiyu Lin, Conghua Lu, et al.. (2024). Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer. Cancer Letters. 588. 216762–216762. 14 indexed citations
2.
Han, Rui, Conghua Lu, Chen Hu, et al.. (2024). Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer. Acta Pharmacologica Sinica. 45(6). 1264–1275. 10 indexed citations
3.
Han, Rui, Caiyu Lin, Chong Zhang, et al.. (2023). The potential therapeutic regimen for overcoming resistance to osimertinib due to rare mutations in NSCLC. iScience. 26(7). 107105–107105. 4 indexed citations
4.
Guo, Jing, Lu Yin, Xin Lin, et al.. (2022). Bioelectrical Impedance Phase Angle as a Predictors of Mortality in Patients with Lung Cancer: a Prospective Study. 7(1). 38–48. 1 indexed citations
5.
Kang, Jun, et al.. (2021). Possible respiratory syncytial virus infection presenting as diffuse alveolar hemorrhage in an elderly treated with systemic corticosteroid: A case report. Respiratory Medicine Case Reports. 33. 101399–101399. 2 indexed citations
6.
Liu, Zhulin, et al.. (2021). Multifocal pleural capillary hemangioma: a rare cause of hemorrhagic pleural effusion-case report. BMC Pulmonary Medicine. 21(1). 156–156.
7.
Yin, Liangyu, Xin Lin, Na Li, et al.. (2020). Evaluation of the Global Leadership Initiative on Malnutrition Criteria Using Different Muscle Mass Indices for Diagnosing Malnutrition and Predicting Survival in Lung Cancer Patients. Journal of Parenteral and Enteral Nutrition. 45(3). 607–617. 68 indexed citations
11.
Wang, Yubo, Rui Han, Zhaojun Chen, et al.. (2016). A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database. Oncology Reports. 35(4). 2257–2269. 12 indexed citations
12.
Li, Li, Peng Zhang, Jun Kang, et al.. (2016). A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non–Small-cell Lung Cancer. Clinical Lung Cancer. 18(3). 340–343. 18 indexed citations
13.
Li, Kunlin, et al.. (2015). Efficacy of recombinant adenoviral human p53 gene in the treatment of lung cancer-mediated pleural effusion. Oncology Letters. 9(5). 2193–2198. 5 indexed citations
14.
Cho, Kyung‐Ja, et al.. (2012). Relationship between histopathology of pleomorphic adenoma in the parotid gland and recurrence after superficial parotidectomy. Journal of Surgical Oncology. 106(8). 942–946. 36 indexed citations
16.
Lee, Jeong-Ju, et al.. (2012). The Ratio of Atypical Ductal Hyperplasia Foci to Core Numbers in Needle Biopsy: A Practical Index Predicting Breast Cancer in Subsequent Excision. The Korean Journal of Pathology. 46(1). 15–15. 1 indexed citations
17.
Kang, Jun, Jeonghyun Cho, Cheol Won Suh, et al.. (2010). High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Annals of Hematology. 90(2). 159–164. 61 indexed citations
18.
Lee, Heejin, Jun Kang, Kyung Mo Kim, et al.. (2009). The Clinicopathological Parameters for Making the Differential Diagnosis of Neonatal Cholestasis. The Korean Journal of Pathology. 43(1). 43–43. 6 indexed citations
19.
Lee, Hae‐Woong, Jun Kang, Mi‐Woo Lee, et al.. (2006). Multiple mucinous and lipomatous variant of eccrine angiomatous hamartoma associated with spindle cell hemangioma: a novel collision tumor?. Journal of Cutaneous Pathology. 33(4). 323–326. 8 indexed citations
20.
Kang, Jun & Inchul Lee. (2006). TuJ1 (class III β-tubulin) as phenotypic marker of lymphatic and venous valves. Cardiovascular Pathology. 15(4). 218–221. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026